| For: | Zeng ZY, Huang ZX, Wang YR, Xie LK, Lin YP, Liang Y, Liu ZY, Li DL, Zhang XY. Anti-RPL30 as a novel biomarker for enhanced diagnosis of autoantibody-negative primary biliary cholangitis. World J Gastroenterol 2025; 31(20): 104891 [PMID: 40495948 DOI: 10.3748/wjg.v31.i20.104891] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i20/104891.htm |
| Number | Citing Articles |
| 1 |
Emina Halilbasic, Elisabeth Tatscher, Elmar Aigner, Lukas Burghart, Ivo Graziadei, Stephanie Hametner-Schreil, Benedikt Silvester Hofer, Harald Hofer, Andreas Maieron, Mattias Mandorfer, Markus Peck-Radosavljevic, Benedikt Schaefer, Wolfgang Sieghart, Martin Stradner, Stefan Traussnigg, Martin Wagner, Heinz Zoller, Peter Fickert, Michael Trauner. Austrian Society of Gastroenterology and Hepatology (ÖGGH) consensus on primary biliary cholangitis. Wiener klinische Wochenschrift 2026; 138(S13) doi: 10.1007/s00508-026-02798-6
|
| 2 |
Raffaele Radice, Giulia Pollaroli, Michela Salvatici, Chiara Corrado, Francesca Rispoli, Stefania Pacchetti, Lorenzo Drago. The Role of Laboratory Markers in Primary Biliary Cholangitis: A Clinical Review and a Case Report. Biomedicines 2026; 14(4) doi: 10.3390/biomedicines14040925
|
| 3 |
Shima Mimura, Asahiro Morishita, Kyoko Oura, Rie Yano, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Miwa Tatsuta, Takashi Himoto, Hideki Kobara. Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. Journal of Clinical Medicine 2025; 14(23) doi: 10.3390/jcm14238503
|